392 related articles for article (PubMed ID: 29361949)
1. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract][Full Text] [Related]
2. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
[No Abstract] [Full Text] [Related]
3. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
[TBL] [Abstract][Full Text] [Related]
4. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-361-5p suppresses the tumorigenesis of hepatocellular carcinoma through targeting WT1 and suppressing WNT/β-cadherin pathway.
Cheng Y; Qiu L; He GL; Cai L; Peng BJ; Cao YL; Pan MX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8823-8832. PubMed ID: 31696469
[TBL] [Abstract][Full Text] [Related]
8. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
Zhao J; Wang Y; Han M; Lu H; Chen X; Liu S; Yuan X; Han K; Liang P; Cheng J
Cancer Sci; 2020 Mar; 111(3):994-1007. PubMed ID: 31746531
[TBL] [Abstract][Full Text] [Related]
9. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
[TBL] [Abstract][Full Text] [Related]
10. MiR-138-5p predicts negative prognosis and exhibits suppressive activities in hepatocellular carcinoma HCC by targeting FOXC1.
Yang G; Guo S; Liu HT; Yang G
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8788-8800. PubMed ID: 32964967
[TBL] [Abstract][Full Text] [Related]
11. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
[TBL] [Abstract][Full Text] [Related]
12. MiR-660-5p promotes the progression of hepatocellular carcinoma by interaction with YWHAH via PI3K/Akt signaling pathway.
Wu Y; Zhang Y; Wang F; Ni Q; Li M
Biochem Biophys Res Commun; 2020 Oct; 531(4):480-489. PubMed ID: 32807493
[TBL] [Abstract][Full Text] [Related]
13. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
[TBL] [Abstract][Full Text] [Related]
14. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
[TBL] [Abstract][Full Text] [Related]
15. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL.
He J; Xiao B; Li X; He Y; Li L; Sun Z
Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317
[TBL] [Abstract][Full Text] [Related]
16. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
17. LncRNA GAS6-AS2 facilitates tumor growth and metastasis of hepatocellular carcinoma by activating the PI3K/AKT/FoxO3a signaling pathway.
Liang C; Pang L; Ke Y; Ji W; Xiong J; Ding R; Ding Y
Int J Clin Exp Pathol; 2019; 12(11):4011-4023. PubMed ID: 31933797
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
19. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
20. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
